Metformin Vitabalans (Metformin Hydrochloride)

Metformin Vitabalans is indicated for conditions related to impaired glucose metabolism and type 2 diabetes management.

• Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose.
• Prediabetes (impaired glucose tolerance): delays progression to overt diabetes when combined with lifestyle changes.
• Polycystic ovary syndrome (off‑label): may improve insulin resistance and menstrual regularity under specialist supervision.

• Metformin acts primarily by inhibiting hepatic gluconeogenesis, thereby decreasing endogenous glucose production. It also enhances peripheral insulin sensitivity by increasing glucose uptake in muscle and adipose tissue and modestly reduces intestinal glucose absorption. The drug activates AMP‑activated protein kinase (AMPK), a key regulator of cellular energy balance, which contributes to its metabolic effects without directly stimulating insulin secretion. Additionally, metformin may improve lipid profiles and modestly aid in weight management.

Metformin Vitabalans may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite.
• Diarrhea: frequent loose stools, often transient.
• Metallic taste: a temporary alteration in taste perception.

Serious or Rare Side Effects

• Lactic acidosis: a potentially fatal buildup of lactic acid, especially in renal impairment.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Vitamin B12 deficiency: decreased absorption with long‑term use.

When prescribing Metformin Vitabalans, clinicians should observe several safety considerations to minimize risks.

• Renal function assessment: evaluate creatinine clearance before initiation and periodically thereafter.
• Hepatic function monitoring: avoid use in patients with significant liver disease.
• Lactic acidosis risk: contraindicated in conditions predisposing to hypoxia or severe infection.
• Vitamin B12 levels: monitor periodically during long‑term therapy to detect deficiency.
• Pregnancy and lactation: use only if potential benefit justifies potential risk; consult specialist.
• Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Metformin Vitabalans can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
• Cimetidine: can raise metformin plasma concentrations.
• Alcohol abuse: enhances risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

• Diuretics (loop or thiazide): may affect renal clearance of metformin.
• Beta‑blockers: can mask hypoglycemia symptoms.
• Other antidiabetic agents (sulfonylureas, insulin): increase risk of hypoglycemia when combined.
• Thyroid hormones: may require dose adjustments of metformin.